KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Long-Term Investments (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Long-Term Investments for 17 consecutive years, with $918.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 3.61% to $918.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $918.0 million through Dec 2025, up 3.61% year-over-year, with the annual reading at $918.0 million for FY2025, 3.61% up from the prior year.
  • Long-Term Investments hit $918.0 million in Q4 2025 for Abbott Laboratories, down from $951.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $958.0 million in Q2 2025 to a low of $734.0 million in Q2 2022.
  • Historically, Long-Term Investments has averaged $834.0 million across 5 years, with a median of $814.0 million in 2021.
  • Biggest five-year swings in Long-Term Investments: decreased 8.82% in 2022 and later rose 15.74% in 2024.
  • Year by year, Long-Term Investments stood at $816.0 million in 2021, then fell by 6.13% to $766.0 million in 2022, then grew by 4.31% to $799.0 million in 2023, then rose by 10.89% to $886.0 million in 2024, then grew by 3.61% to $918.0 million in 2025.
  • Business Quant data shows Long-Term Investments for ABT at $918.0 million in Q4 2025, $951.0 million in Q3 2025, and $958.0 million in Q2 2025.